SSA
TXG icon

Schonfeld Strategic Advisors’s 10x Genomics TXG Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41M Buy
+113,724
New +$2.27M 0.02% 745
2025
Q4 		– Sell
-82,126
Closed -$960K – 2597
2025
Q3 		$960K Buy
82,126
+24,639
+43% +$321K 0.01% 1387
2025
Q2 		$666K Buy
57,487
+26,558
+86% +$242K ﹤0.01% 1452
2025
Q1 		$270K Sell
30,929
-120,764
-80% -$1.52M ﹤0.01% 1833
2024
Q4 		$2.18M Buy
151,693
+88,583
+140% +$1.4M 0.01% 797
2024
Q3 		$1.43M Buy
63,110
+37,890
+150% +$783K 0.01% 1033
2024
Q2 		$491K Sell
25,220
-7,477
-23% -$196K ﹤0.01% 1502
2024
Q1 		$1.23M Buy
32,697
+11,047
+51% +$485K 0.01% 1154
2023
Q4 		$1.21M Buy
+21,650
New +$942K 0.01% 967
2023
Q3 		– Sell
-8,800
Closed -$491K – 2304
2023
Q2 		$491K Buy
+8,800
New +$476K ﹤0.01% 1229
2022
Q4 		– Sell
-34,200
Closed -$974K – 3023
2022
Q3 		$974K Buy
+34,200
New +$1.3M 0.01% 1283
2021
Q2 		– Sell
-12,281
Closed -$2.22M – 2328
2021
Q1 		$2.22M Sell
12,281
-219
-2% -$37.8K 0.03% 632
2020
Q4 		$1.77M Buy
12,500
+2,630
+27% +$382K 0.02% 629
2020
Q3 		$1.23M Buy
9,870
+770
+8% +$80.8K 0.02% 651
2020
Q2 		$813K Hold
9,100
– – 0.02% 670
2020
Q1 		$567K Buy
+9,100
New +$710K 0.04% 540

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's TXG Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in 10x Genomics (TXG) in Q1 2026: 113,724 shares worth $2.41M. The stake represents 0.02% of the portfolio and ranks #745 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in TXG as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in TXG in Q1 2020 and has held it in 16 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Schonfeld Strategic Advisors held 113,724 shares of 10x Genomics worth $2.41M as of Q1 2026.
  • 10x Genomics was a new Schonfeld Strategic Advisors position in Q1 2026.
  • 10x Genomics made up 0.02% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #745 holding.
  • Schonfeld Strategic Advisors first reported a position in 10x Genomics in Q1 2020 and has held it in 16 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.